Sonoma Pharmaceuticals, Inc. SNOA US Equity☆

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), an SEC filer in Surgical & Medical Instruments & Apparatus, closed at $1.31, -1.5%, on 2026-08-28, with a market cap of $6M as of 2026-08-27, a return on equity of -84.6%, a net margin of -16.3% and 3-year sales growth of 13.7%. Institutional ownership, earnings history and filed financials are on the tabs below.